MedPath

A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray

Not Applicable
Completed
Conditions
Skin Care
Interventions
Other: Reference product
Other: Negative control
Other: Prototype disinfectant spray formulation
Registration Number
NCT02106403
Lead Sponsor
GlaxoSmithKline
Brief Summary

The objective of this randomised, examiner and subject blinded study is to evaluate and compare cooling performance and overall consumer liking of the prototype formulation with the currently marketed wound spray and negative control in subjects with experimental wounds. For each subject, three superficial wounds will be induced on two volar forearms, by sequential tape strippings until a glistening layer is visualized. After wounding, a randomised test product will be sprayed twice on test site, and the subject will be asked to complete a questionnaire evaluating product cooling performance and overall liking.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Participants in good health with healthy and intact skin on the test area
  • Age 18-60 years
Read More
Exclusion Criteria
  • Pregnancy or breast-feeding
  • Allergy/Intolerance
  • Participants currently taking any topical or systemic treatments that may interfere with or mask the test results
  • Participants who have taken any topical anti-inflammation treatment in the application area in past 2 months
  • Participants who are vulnerable to any intervention
  • Damaged skin close to test site, active skin disorders, any visible skin disorder
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Reference productReference product0.13% w/w BAC. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound
Negative controlNegative control0.9% w/v sodium chloride solution. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound
Prototype disinfectant spray formulationPrototype disinfectant spray formulation0.13% w/w Benzalkonium Chloride (BAC) and 1% Menthone Glycerin Acetal (MGA). After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound
Primary Outcome Measures
NameTimeMethod
Participant-perceived Cooling Sensation at 5 MinAt 5 min after product application

The cooling sensation was assessed on VAS (0-100 mm, where 0= no cooling and 100= extreme cooling) at 5 min post study product application.

Participant-perceived Cooling Sensation at 15 MinAt 15 min after product application

The cooling sensation was assessed on VAS (0-100 mm, where 0= no cooling and 100= extreme cooling) at 15 min post study product application.

Participant-perceived Cooling Sensation Immediately Post Product ApplicationImmediately after product application

The cooling sensation was assessed immediately after the study product application on 100 millimeter (mm) Visual Analogue Scale (VAS) (0-100 mm, where 0= no cooling and 100= extreme cooling).

Participant-perceived Cooling Sensation at 3 MinAt 3 min after product application

The cooling sensation was assessed on VAS (0-100 mm, where 0= no cooling and 100= extreme cooling) at 3 min post study product application.

Secondary Outcome Measures
NameTimeMethod
Overall Sensory Liking of Study ProductsImmediatey, 3 min, 5 min and 15 min after product application

Overall sensory liking of the study products was assessed immediately, 3min, 5 min and 15 min after products application. The assessment was done on a 9 point categorical scale where 1= Dislike it extremely, 2= Dislike it very much, 3= Dislike it moderately, 4= Dislike it slightly, 5= Neither like it nor dislike it, 6= Like it slightly, 7= Like it moderately, 8= Like it very much, 9= Like it extremely.

Trial Locations

Locations (1)

Guangzhou Landproof Testing Technology Co., LTD

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath